Search

A team of Memorial Sloan Kettering clinicians and computational biologists have compiled the largest catalog to date of genetic alterations that occur in prostate cancer.

A new pilot study by investigators at Memorial Sloan Kettering Cancer Center found that breast cancer patients can be treated safely with a "dose-dense" regimen of standard chemotherapy agents and the antibody trastuzumab (Herceptin®), a drug that has previously been shown to cause cardiac toxicity.

MSK ranked #15 across all companies and industries in New York State (NYS) and #2 in the NYS Healthcare & Social Industry.

Thanks to MSK’s expertise in treating young people with cancer, 16-year-old high school athlete Sammy is back to doing what he loves.

Some children enjoy playing with blocks, dolls, and toy cars. Dr. Ying Liu, a gynecologic medical oncologist and attending in the Clinical Genetics Service at Memorial Sloan Kettering, was fascinated by the test tubes in her mother’s laboratory. Dr. Liu didn’t know it then, but holding those sleek glass cylinders was the same as looking into a crystal ball.

Memorial Sloan Kettering’s Melanoma Disease Management Team understands the importance of helping these patients maximize the opportunities and overcome the challenges that arise in their lives.

Kathryn V. Anderson has been elected a member of the Institute of Medicine of the National Academies.

Given the current pandemic, every time a healthcare provider asks a patient to come in for an appointment, they’re making a mental calculation of the risk and benefit. Utilizing telemedicine has allowed providers at Memorial Sloan Kettering (MSK) to keep patients safely sheltered at home, while continuing to provide their necessary care.